Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Eculizumab in STEC-HUS with severe neurological involvement: a New Zealand perspective.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: Springer International Country of Publication: Germany NLM ID: 8708728 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-198X (Electronic) Linking ISSN: 0931041X NLM ISO Abbreviation: Pediatr Nephrol Subsets: MEDLINE
- Publication Information:
Publication: Berlin : Springer International
Original Publication: Berlin : Springer International, c1987-
- Subject Terms:
- References:
Wong W (2021) Shiga toxin producing Escherichia coli infections and associated haemolytic uraemic syndrome in New Zealand children: twenty three years of epidemiology and clinical observations. Int J Pediatr Res 8:085.
Wildes DM, Harvey S, Costigan CS, Sweeney C, Twomey É, Awan A et al (2023) Eculizumab in STEC-HUS: a paradigm shift in the management of pediatric patients with neurological involvement. Pediatr Nephrol. https://doi.org/10.1007/s00467-023-06102-w.
Pape L, Hartmann H, Bange FC, Suerbaum S, Bueltmann E, Ahlenstiel-Grunow T (20215) Eculizumab in typical hemolytic uremic syndrome (HUS) with neurological involvement. Medicine (Baltimore) 94:e1000.
Giordano P, Netti GS, Santangelo L, Castellano G, Carbone V, Torres DD et al (2019) A pediatric neurologic assessment score may drive the eculizumab-based treatment of Escherichia coli-related hemolytic uremic syndrome with neurological involvement. Pediatr Nephrol 34:517–527. (PMID: 10.1007/s00467-018-4112-230362078)
- Accession Number:
A3ULP0F556 (eculizumab)
0 (Antibodies, Monoclonal, Humanized)
- Publication Date:
Date Created: 20231130 Date Completed: 20240419 Latest Revision: 20240419
- Publication Date:
20240419
- Accession Number:
10.1007/s00467-023-06226-z
- Accession Number:
38032416
No Comments.